Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort

Lemis Yavuz1,2, Sarmad AlHamdani3, Samah Alasrawi4

  • 1Al Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates. osmanlames@hotmail.com.

Insights

Kawasaki disease (KD) and Multi-system Inflammatory Syndrome in Children (MIS-C) share similarities but have distinct features. This study developed a formula to differentiate between KD and MIS-C, suggesting MIS-C may be a severe variant of KD.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Kawasaki disease (KD) and Multi-system Inflammatory Syndrome in Children (MIS-C) are pediatric inflammatory conditions with overlapping clinical presentations.
  • Differentiating between KD and MIS-C is crucial for appropriate management and understanding disease spectrums.

Purpose of the Study:

  • To conduct a comprehensive characteristic study of KD and MIS-C in the Middle East.
  • To develop a formula for differentiating between KD and MIS-C based on clinical and laboratory findings.

Main Methods:

  • A descriptive comparative study was conducted in the United Arab Emirates.
  • Retrospective cohorts of KD and MIS-C patients (January 2017-August 2021) were analyzed.
  • Clinical and laboratory data were compared between groups and with literature data.

Main Results:

  • 123 patients were analyzed: 67 with KD and 56 with MIS-C.
  • MIS-C patients were older (median 7.3 years vs. 2.2 years for KD) and presented more gastrointestinal symptoms (84% vs. 31%).
  • KD showed higher white blood cells, neutrophils, lymphocytes, ESR, and platelets, while MIS-C had elevated procalcitonin and ferritin. Cardiac dysfunction and PICU admission were higher in MIS-C.

Conclusions:

  • KD and MIS-C exhibit significant similarities, suggesting they may exist on a similar clinical spectrum.
  • Distinct differences indicate MIS-C could represent a severe variant of KD.
  • A novel formula was developed to aid in differentiating between KD and MIS-C.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
40
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K